CN109646641A - 一种用于治疗骨折的外用组合物及其制备方法 - Google Patents
一种用于治疗骨折的外用组合物及其制备方法 Download PDFInfo
- Publication number
- CN109646641A CN109646641A CN201910127359.8A CN201910127359A CN109646641A CN 109646641 A CN109646641 A CN 109646641A CN 201910127359 A CN201910127359 A CN 201910127359A CN 109646641 A CN109646641 A CN 109646641A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fracture
- topical composition
- cortex eucommiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 230000000699 topical effect Effects 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 22
- 244000235603 Acacia catechu Species 0.000 claims abstract description 22
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 22
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 22
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 22
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 22
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 22
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 22
- 241000123589 Dipsacus Species 0.000 claims abstract description 22
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 22
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 22
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 22
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 22
- 244000292697 Polygonum aviculare Species 0.000 claims abstract description 22
- 235000006386 Polygonum aviculare Nutrition 0.000 claims abstract description 22
- 241000270295 Serpentes Species 0.000 claims abstract description 22
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 22
- 229910052802 copper Inorganic materials 0.000 claims abstract description 22
- 239000010949 copper Substances 0.000 claims abstract description 22
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 22
- 239000009136 dragon's blood Substances 0.000 claims abstract description 22
- 210000003278 egg shell Anatomy 0.000 claims abstract description 22
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 22
- 235000013372 meat Nutrition 0.000 claims abstract description 22
- 235000013976 turmeric Nutrition 0.000 claims abstract description 22
- 241001148782 Davallia Species 0.000 claims abstract description 21
- 244000290970 Tetrapanax papyrifer Species 0.000 claims abstract description 21
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 21
- 241000195947 Lycopodium Species 0.000 claims abstract description 12
- 241000227129 Aconitum Species 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 19
- 241000717739 Boswellia sacra Species 0.000 claims description 17
- 239000004863 Frankincense Substances 0.000 claims description 17
- 240000007311 Commiphora myrrha Species 0.000 claims description 15
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 15
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 15
- 238000007873 sieving Methods 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 230000000202 analgesic effect Effects 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 3
- 210000002435 tendon Anatomy 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 206010017076 Fracture Diseases 0.000 description 62
- 208000010392 Bone Fractures Diseases 0.000 description 61
- 244000025254 Cannabis sativa Species 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- -1 crush Substances 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 10
- 208000005214 Poroma Diseases 0.000 description 8
- 201000001013 eccrine acrospiroma Diseases 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 206010020649 Hyperkeratosis Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 3
- 206010018852 Haematoma Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000006670 Multiple fractures Diseases 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000032631 intramembranous ossification Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000008924 Femoral Fractures Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 206010034246 Pelvic fractures Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Insects & Arthropods (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药技术领域,公开了一种用于治疗骨折的外用组合物及其制备方法,所述外用组合物包括如下重量份数的组分:当归5‑50份;草乌5‑20份;川乌5‑20份;鸡血藤5‑40份;苏木5‑40份;骨碎补5‑40份;龙骨粉5‑50份;自然铜5‑50份;血竭5‑50份;伸筋草5‑40份;杜仲5‑30份;红花5‑20份;海马5‑50份;碎蛇5‑60份;续断5‑20份;文术5‑20份;赤芍5‑20份;三七5‑50份;通草5‑20份;杜仲5‑20份;郁金5‑20份;木通5‑20份;姜黄5‑30份;川芎5‑30份;血余炭5‑30份;儿茶5‑40份;首乌5‑50份;黄芪5‑20份;蟹粉5‑40份和鸡蛋壳5‑60份。本发明具有活血祛风、舒筋活络、消炎止痛、接骨续筋、促进骨折愈合的功效。
Description
技术领域
本发明属于中药技术领域,具体涉及一种用于治疗骨折的外用组合物及其制备方法。
背景技术
骨折是指骨结构的连续性完全或部分断裂。多见于儿童及老年人,中青年人也时有发生。病人常为—个部位骨折,少数为多发性骨折。经及时恰当处理,多数病人能恢复原来的功能,少数病人可遗留有不同程度的后遗症。
发生骨折后会产生一些临床表现。对于多发性骨折、骨盆骨折、股骨骨折、脊柱骨折及严重的开放性骨折,患者常因广泛的软组织损伤、大量出血、剧烈疼痛或并发内脏损伤等而引起休克;骨折处有大量内出血,血肿吸收时体温略有升高,但一般不超过38℃,开放性骨折体温升高时应考虑感染的可能;骨折病人的典型表现是伤后出现局部变形、肢体等出现异常运动、移动肢体时可听到骨擦音。此外,伤口剧痛,局部肿胀、淤血,伤后出现运动障碍。骨折的诊断一般根据临床表现及影像学检查如X光即可确诊或排除诊断。
骨折愈合的过程就是“瘀去、新生、骨合”的过程,是一面清除坏死组织,一面新生修复的过程(由膜内化骨与软骨内化骨共同完成),整个过程是持续的和渐进的。骨折愈合的过程也是暂时性紧急连接到永久性坚固连接的过程。一般将骨折愈合分为3个阶段,即血肿机化期、原始骨痂形成期和骨痂改造塑形期;也有根据骨折愈合过程的组织学和生理学特征分为撞击期、诱导期、炎症期、软骨痂期、硬骨痂期和改建期6个不同的阶段。
血肿机化期:骨折后,因骨折本身及邻近软组织的血管断裂出血,在骨折部形成了血肿,血肿于伤后6-8小时即开始凝结成血块,与局部坏死组织引起无菌性炎性反应。骨折断端因血循环中断,逐渐发生坏死,约有数毫米长。随着纤维蛋白的渗出,毛细血管的增生,成纤维细胞、吞噬细胞的侵入,血肿逐渐机化,形成肉芽组织,并进而演变成纤维结缔组织,使骨折断端初步连接在一起,称为纤维连接,约在骨折后2-3周内完成。同时,骨折端附近骨外膜的成骨细胞伤后不久即活跃增生,一周后即开始形成与骨干平行的骨样组织,并逐渐向骨折处延伸增厚。骨内膜在稍晚是亦发生同样改变。
原始骨痂形成期:原始骨痂形成或骨内膜和骨外膜的成骨细胞增生,在骨折端内、外形成的骨组织逐渐骨化,形成新骨,称为膜内化骨。随新骨的不断增多,紧贴骨皮质内在治疗骨折时,对这些并发症应以预防为主,如果已经出现则应及时诊断和妥善治疗,这样,大多数并发症都是可以避免或治愈的。外面逐渐向骨折端生长,彼此会合形成梭形,称为内骨痂和外骨痂。骨折断端及髓腔内的纤维组织亦逐渐转化为软骨组织,并随软骨细胞的增生、钙化而骨化,称为软骨内化骨,而在骨折处形成环状骨痂和髓腔内骨痂。两部分骨痂会合后,这些原始骨痂不断钙化而逐渐加强,当其达到足以抵抗肌收缩及成角、剪力和旋转力时,则骨折已达到临床愈合,在成人一般约需12-24周(人卫版外科学教材第8版最新修改)。此时X线片上可见骨折处四周有梭形骨痂阴影,但骨折线仍隐约可见。对骨外膜的损伤均对骨折愈合不利。
骨痂改造塑形期:原始骨痂中新生骨小梁逐渐增加,且排列逐渐规则和致密,骨折断端经死骨清除和新骨形成的爬行代替而复活,骨折部位形成骨性连接。这一过程一般约需1-2年。随着肢体活动和负重,应力轴线上的骨痂不断得到加强,应力轴线以外的骨痂逐渐被清除,并且骨髓腔重新沟通,恢复骨的正常结构,最终骨折的痕迹从组织学和放射学上完全消失。
然而,现有的治疗骨折的西医方式往往采用自然愈合的过程,患者在治疗过程中往往需要承受巨大的痛苦,对患者生理和心理都产生了较消极的影响;而骨折患者需要慢慢等骨骼自行愈合,而现有的中药配方无法有效促进骨骼的愈合和减轻愈合过程中患处的病痛。
发明内容
为了解决现有技术存在的上述问题,本发明目的在于提供一种用于治疗骨折的外用组合物及其制备方法。
本发明所采用的技术方案为:
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归5-50份;草乌5-20份;川乌5-20份;鸡血藤5-40份;苏木5-40份;骨碎补5-40份;龙骨粉5-50份;自然铜5-50份;血竭5-50份;伸筋草5-40份;杜仲5-30份;红花5-20份;海马5-50份;碎蛇5-60份;续断5-20份;文术5-20份;赤芍5-20份;三七5-50份;通草5-20份;杜仲5-20份;郁金5-20份;木通5-20份;姜黄5-30份;川芎5-30份;血余炭5-30份;儿茶5-40份;首乌5-50份;黄芪5-20份;蟹粉5-40份和鸡蛋壳5-60份。
进一步的,所述的一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归10-40份;草乌10-15份;川乌10-15份;鸡血藤10-30份;苏木10-30份;骨碎补10-30份;龙骨粉10-40份;自然铜10-40份;血竭10-40份;伸筋草10-35份;杜仲10-25份;红花10-15份;海马10-40份;碎蛇10-50份;续断10-15份;文术10-15份;赤芍10-15份;三七10-40份;通草10-15份;杜仲10-15份;郁金10-15份;木通10-15份;姜黄10-20份;川芎10-20份;血余炭10-20份;儿茶10-30份;首乌10-40份;黄芪10-15份;蟹粉10-30份和鸡蛋壳10-50份。
进一步的,所述的一种用于治疗骨折的外用组合物,还包括如下重量份数的组分:乳香5-40份和没药5-40份。
进一步的,所述的一种用于治疗骨折的外用组合物,还包括如下重量份数的组分:乳香15-30份和没药15-30份。
进一步的,所述的一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归30份;草乌12份;川乌12份;鸡血藤20份;苏木20份;骨碎补20份;龙骨粉30份;自然铜30份;血竭30份;伸筋草22份;杜仲22份;红花12份;海马30份;碎蛇35份;续断12份;文术12份;赤芍12份;三七30份;通草13份;杜仲13份;郁金13份;木通13份;姜黄15份;川芎15份;血余炭15份;儿茶15份;首乌25份;黄芪12份;蟹粉20份;鸡蛋壳30份;乳香20份和没药20份。
进一步的,所述外用组合物的剂型为散剂。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
本发明的有益效果为:本发明的一种用于治疗骨折的外用组合物及其制备方法,通过黄芪、当归、川芎、血余炭、血竭、红花、三七、郁金起到补血和血、止血、活血止痛行气解郁的作用;儿茶活血止痛,收敛湿疮;本发明的苏木、自然铜起到行气活血消肿止痛,散瘀接骨的作用;杜仲、续断、骨碎补散瘀止痛、接骨续筋;龙骨粉生肌敛疮;鸡蛋壳、蟹粉收敛制酸,补钙;从而起到促进骨骼愈合回复的作用;赤芍、木通凉血祛瘀,清热除烦;首乌、草乌、川乌祛风除湿温经止痛;姜黄破血行气,止痛;乳香、没药、文术行气活血止痛;伸筋草、鸡血藤、海马、碎蛇散瘀祛风、舒筋活络、消炎止痛;通草清热利水消除痈疽;将本发明的组合物制成散剂使用,本发明具有药效持久的特点;从而本发明通过活血祛风、舒筋活络、消炎止痛、接骨续筋起到了促进骨折愈合的功效。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。
一、药物组成
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归5-50份;草乌5-20份;川乌5-20份;鸡血藤5-40份;苏木5-40份;骨碎补5-40份;龙骨粉5-50份;自然铜5-50份;血竭5-50份;伸筋草5-40份;杜仲5-30份;红花5-20份;海马5-50份;碎蛇5-60份;续断5-20份;文术5-20份;赤芍5-20份;三七5-50份;通草5-20份;杜仲5-20份;郁金5-20份;木通5-20份;姜黄5-30份;川芎5-30份;血余炭5-30份;儿茶5-40份;首乌5-50份;黄芪5-20份;蟹粉5-40份和鸡蛋壳5-60份。
一种用于治疗骨折的外用组合物,还包括如下重量份数的组分:乳香5-40份和没药5-40份。
为了达到更好的效果,优化组成如下:
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归10-40份;草乌10-15份;川乌10-15份;鸡血藤10-30份;苏木10-30份;骨碎补10-30份;龙骨粉10-40份;自然铜10-40份;血竭10-40份;伸筋草10-35份;杜仲10-25份;红花10-15份;海马10-40份;碎蛇10-50份;续断10-15份;文术10-15份;赤芍10-15份;三七10-40份;通草10-15份;杜仲10-15份;郁金10-15份;木通10-15份;姜黄10-20份;川芎10-20份;血余炭10-20份;儿茶10-30份;首乌10-40份;黄芪10-15份;蟹粉10-30份和鸡蛋壳10-50份。
所述的一种用于治疗骨折的外用组合物,还包括如下重量份数的组分:乳香15-30份和没药15-30份。
进一步的,优化组成如下:
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归30份;草乌12份;川乌12份;鸡血藤20份;苏木20份;骨碎补20份;龙骨粉30份;自然铜30份;血竭30份;伸筋草22份;杜仲22份;红花12份;海马30份;碎蛇35份;续断12份;文术12份;赤芍12份;三七30份;通草13份;杜仲13份;郁金13份;木通13份;姜黄15份;川芎15份;血余炭15份;儿茶15份;首乌25份;黄芪12份;蟹粉20份;鸡蛋壳30份;乳香20份和没药20份。
二、使用方法
将所述外用组合物制成散剂使用。
或采用如下制备方法制成散剂使用:
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
本申请与本申请人同日申请的一种接骨续筋的外用组合物及其制备方法配合使用,效果更佳。
三、功能主治
适用于骨折患者患处愈合过程使用。
四、实施例
实施例1
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归5份;草乌5份;川乌5份;鸡血藤5份;苏木5份;骨碎补5份;龙骨粉5份;自然铜5份;血竭5份;伸筋草5份;杜仲5份;红花5份;海马5份;碎蛇5份;续断5份;文术5份;赤芍5份;三七5份;通草5份;杜仲5份;郁金5份;木通5份;姜黄5份;川芎5份;血余炭5份;儿茶5份;首乌5份;黄芪5份;蟹粉5份;鸡蛋壳5份;乳香5份和没药5份。
将所述外用组合物制成散剂使用。
实施例2
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归50份;草乌20份;川乌20份;鸡血藤40份;苏木40份;骨碎补40份;龙骨粉50份;自然铜50份;血竭50份;伸筋草40份;杜仲30份;红花20份;海马50份;碎蛇60份;续断20份;文术20份;赤芍20份;三七50份;通草20份;杜仲20份;郁金20份;木通20份;姜黄30份;川芎30份;血余炭30份;儿茶40份;首乌50份;黄芪20份;蟹粉40份;鸡蛋壳60份;乳香40份和没药40份。
将所述外用组合物制成散剂使用。
实施例3
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归5-50份;草乌15份;川乌15份;鸡血藤35份;苏木35份;骨碎补35份;龙骨粉40份;自然铜40份;血竭40份;伸筋草35份;杜仲25份;红花15份;海马40份;碎蛇45份;续断15份;文术15份;赤芍15份;三七45份;通草15份;杜仲15份;郁金15份;木通15份;姜黄15份;川芎20份;血余炭25份;儿茶35份;首乌45份;黄芪15份;蟹粉35份;鸡蛋壳45份;乳香35份和没药45份。
将所述外用组合物制成散剂使用。
实施例4
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归10份;草乌10份;川乌10份;鸡血藤10份;苏木10份;骨碎补10份;龙骨粉10份;自然铜10份;血竭10份;伸筋草10份;杜仲10份;红花10份;海马10份;碎蛇10份;续断10份;文术10份;赤芍10份;三七10份;通草10份;杜仲10份;郁金10份;木通10份;姜黄10份;川芎10份;血余炭10份;儿茶10份;首乌10份;黄芪10份;蟹粉10份;鸡蛋壳10份;乳香15份和没药15份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例5
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归40份;草乌15份;川乌15份;鸡血藤30份;苏木30份;骨碎补30份;龙骨粉40份;自然铜40份;血竭40份;伸筋草35份;杜仲25份;红花15份;海马40份;碎蛇50份;续断15份;文术15份;赤芍15份;三七40份;通草15份;杜仲15份;郁金15份;木通15份;姜黄20份;川芎20份;血余炭20份;儿茶30份;首乌40份;黄芪15份;蟹粉30份;鸡蛋壳50份;乳香30份和没药30份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例6
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归40份;草乌15份;川乌15份;鸡血藤30份;苏木30份;骨碎补30份;龙骨粉40份;自然铜40份;血竭40份;伸筋草35份;杜仲25份;红花15份;海马40份;碎蛇50份;续断15份;文术15份;赤芍15份;三七40份;通草15份;杜仲15份;郁金15份;木通15份;姜黄20份;川芎20份;血余炭20份;儿茶30份;首乌40份;黄芪15份;蟹粉30份;鸡蛋壳50份;乳香30份和没药30份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例7
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归30份;草乌12份;川乌12份;鸡血藤20份;苏木20份;骨碎补20份;龙骨粉30份;自然铜30份;血竭30份;伸筋草22份;杜仲22份;红花12份;海马30份;碎蛇35份;续断12份;文术12份;赤芍12份;三七30份;通草13份;杜仲13份;郁金13份;木通13份;姜黄15份;川芎15份;血余炭15份;儿茶15份;首乌25份;黄芪12份;蟹粉20份;鸡蛋壳30份;乳香20份和没药20份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例8
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归12份;草乌7份;川乌7份;鸡血藤9份;苏木9份;骨碎补9份;龙骨粉12份;自然铜12份;血竭10份;伸筋草12份;杜仲15份;红花10份;海马10份;碎蛇15份;续断12份;文术12份;赤芍12份;三七12份;通草15份;杜仲12份;郁金14份;木通14份;姜黄12份;川芎12份;血余炭15份;儿茶15份;首乌20份;黄芪15份;蟹粉15份和鸡蛋壳25份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例9
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归30份;草乌10份;川乌10份;鸡血藤20份;苏木20份;骨碎补20份;龙骨粉35份;自然铜20份;血竭25份;伸筋草20份;杜仲25份;红花12份;海马25份;碎蛇35份;续断15份;文术16份;赤芍18份;三七36份;通草14份;杜仲16份;郁金16份;木通16份;姜黄22份;川芎22份;血余炭25份;儿茶34份;首乌42份;黄芪15份;蟹粉35份和鸡蛋壳40份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例10
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归40份;草乌10份;川乌14份;鸡血藤32份;苏木32份;骨碎补35份;龙骨粉45份;自然铜45份;血竭45份;伸筋草45份;杜仲25份;红花14份;海马16份;碎蛇45份;续断17份;文术17份;赤芍17份;三七35份;通草14份;杜仲17份;郁金18份;木通16份;姜黄15份;川芎20份;血余炭14份;儿茶35份;首乌42份;黄芪14份;蟹粉32份和鸡蛋壳44份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
实施例11
一种用于治疗骨折的外用组合物,包括如下重量份数的组分:当归48份;草乌16份;川乌18份;鸡血藤35份;苏木35份;骨碎补35份;龙骨粉48份;自然铜42份;血竭45份;伸筋草38份;杜仲28份;红花18份;海马48份;碎蛇45份;续断15份;文术15份;赤芍15份;三七48份;通草15份;杜仲15份;郁金15份;木通15份;姜黄25份;川芎25份;血余炭25份;儿茶35份;首乌40份;黄芪15份;蟹粉35份和鸡蛋壳45份。
一种用于治疗骨折的外用组合物的制备方法,包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
本发明不局限于上述可选的实施方式,任何人在本发明的启示下都可得出其他各种形式的产品。上述具体实施方式不应理解成对本发明的保护范围的限制,本发明的保护范围应当以权利要求书中界定的为准,并且说明书可以用于解释权利要求书。
Claims (7)
1.一种用于治疗骨折的外用组合物,其特征在于:包括如下重量份数的组分:当归5-50份;草乌5-20份;川乌5-20份;鸡血藤5-40份;苏木5-40份;骨碎补5-40份;龙骨粉5-50份;自然铜5-50份;血竭5-50份;伸筋草5-40份;杜仲5-30份;红花5-20份;海马5-50份;碎蛇5-60份;续断5-20份;文术5-20份;赤芍5-20份;三七5-50份;通草5-20份;杜仲5-20份;郁金5-20份;木通5-20份;姜黄5-30份;川芎5-30份;血余炭5-30份;儿茶5-40份;首乌5-50份;黄芪5-20份;蟹粉5-40份和鸡蛋壳5-60份。
2.根据权利要求1所述的一种用于治疗骨折的外用组合物,其特征在于:包括如下重量份数的组分:当归10-40份;草乌10-15份;川乌10-15份;鸡血藤10-30份;苏木10-30份;骨碎补10-30份;龙骨粉10-40份;自然铜10-40份;血竭10-40份;伸筋草10-35份;杜仲10-25份;红花10-15份;海马10-40份;碎蛇10-50份;续断10-15份;文术10-15份;赤芍10-15份;三七10-40份;通草10-15份;杜仲10-15份;郁金10-15份;木通10-15份;姜黄10-20份;川芎10-20份;血余炭10-20份;儿茶10-30份;首乌10-40份;黄芪10-15份;蟹粉10-30份和鸡蛋壳10-50份。
3.根据权利要求1或2所述的一种用于治疗骨折的外用组合物,其特征在于:还包括如下重量份数的组分:乳香5-40份和没药5-40份。
4.根据权利要求3所述的一种用于治疗骨折的外用组合物,其特征在于:还包括如下重量份数的组分:乳香15-30份和没药15-30份。
5.根据权利要求4所述的一种用于治疗骨折的外用组合物,其特征在于:包括如下重量份数的组分:当归30份;草乌12份;川乌12份;鸡血藤20份;苏木20份;骨碎补20份;龙骨粉30份;自然铜30份;血竭30份;伸筋草22份;杜仲22份;红花12份;海马30份;碎蛇35份;续断12份;文术12份;赤芍12份;三七30份;通草13份;杜仲13份;郁金13份;木通13份;姜黄15份;川芎15份;血余炭15份;儿茶15份;首乌25份;黄芪12份;蟹粉20份;鸡蛋壳30份;乳香20份和没药20份。
6.根据权利要求5所述的一种用于治疗骨折的外用组合物,其特征在于:所述外用组合物的剂型为散剂。
7.一种权利要求5所述的一种用于治疗骨折的外用组合物的制备方法,其特征在于:包括步骤:将各个组分混匀、粉碎、过筛后制成散剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910127359.8A CN109646641A (zh) | 2019-02-20 | 2019-02-20 | 一种用于治疗骨折的外用组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910127359.8A CN109646641A (zh) | 2019-02-20 | 2019-02-20 | 一种用于治疗骨折的外用组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109646641A true CN109646641A (zh) | 2019-04-19 |
Family
ID=66123366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910127359.8A Pending CN109646641A (zh) | 2019-02-20 | 2019-02-20 | 一种用于治疗骨折的外用组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109646641A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494578A (zh) * | 2020-05-27 | 2020-08-07 | 苏雅拉图 | 一种促进骨折愈合的蒙药及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090317494A1 (en) * | 2008-06-23 | 2009-12-24 | Xiuying Lin | Herbal composition containing COX-2 and its manufacturing method |
CN102091202A (zh) * | 2011-01-17 | 2011-06-15 | 赵献民 | 一种治疗骨折的中药组合物及其制备方法 |
CN104887886A (zh) * | 2014-03-04 | 2015-09-09 | 易泽瑜 | 跌打骨折愈伤膏 |
CN107714971A (zh) * | 2017-10-26 | 2018-02-23 | 刘恩国 | 一种治疗骨折的中药组合物及其制备方法 |
-
2019
- 2019-02-20 CN CN201910127359.8A patent/CN109646641A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090317494A1 (en) * | 2008-06-23 | 2009-12-24 | Xiuying Lin | Herbal composition containing COX-2 and its manufacturing method |
CN102091202A (zh) * | 2011-01-17 | 2011-06-15 | 赵献民 | 一种治疗骨折的中药组合物及其制备方法 |
CN104887886A (zh) * | 2014-03-04 | 2015-09-09 | 易泽瑜 | 跌打骨折愈伤膏 |
CN107714971A (zh) * | 2017-10-26 | 2018-02-23 | 刘恩国 | 一种治疗骨折的中药组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494578A (zh) * | 2020-05-27 | 2020-08-07 | 苏雅拉图 | 一种促进骨折愈合的蒙药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104147577B (zh) | 一种用于促进骨痂生长治疗骨折的膏药 | |
CN109820585B (zh) | 微创髓内板系统 | |
CN109646641A (zh) | 一种用于治疗骨折的外用组合物及其制备方法 | |
CN102861196B (zh) | 一种接骨中药 | |
CN101352506B (zh) | 一种治疗骨科疾病的药物及其制备方法和应用 | |
CN109620938A (zh) | 一种接骨续筋的外用组合物及其制备方法 | |
CN103385985B (zh) | 一种快速接筋骨的中草药组合物 | |
CN105641748B (zh) | 一种可注射植骨材料及制备方法 | |
CN1903246B (zh) | 接骨药 | |
CN101342287A (zh) | 一种快速接骨、舒筋活血化瘀药膏及其制备方法 | |
CN106344679A (zh) | 一种中药膏 | |
CN1202853C (zh) | 一种跌打接骨膏剂及其配制方法 | |
CN1060358C (zh) | 骨质增生软膏 | |
CN105106288A (zh) | 一种自拟复元骨愈汤 | |
CN109620926B (zh) | 一种改善伤筋骨折术后肢体肿胀、麻木及活动障碍的中药外洗方 | |
CN102091204B (zh) | 治疗跌打损伤、深部静脉炎的中药组合物及其制法与应用 | |
Gen et al. | A review of platelet-rich plasma in the treatment of rotator cuff injury | |
Pop et al. | Conservative Treatment of Fractures Increases the Risk of Deep Vein Compared to Surgical Treatment in Animal Model | |
Deng et al. | Cortical perforation combined with Masquelet technique to treat extensive bone and soft tissue injury: A case report | |
Wang et al. | Effective Kirschner wire fixation for tissue necrosis of open comminuted tibial plateau fracture: A case report and literature review | |
CN104840473A (zh) | 丹参酮ⅱa在制备治疗肌腱粘连的药物中的应用 | |
CN110812467A (zh) | 一种外用促进骨折康复的松桂香精油 | |
CN112972634A (zh) | 一种治疗跌打损伤的药物 | |
CN116474026A (zh) | 一种用于治疗骨折、骨裂的生骨散 | |
CN1634323A (zh) | 治疗骨折的内服外用药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190419 |
|
RJ01 | Rejection of invention patent application after publication |